Lipid peroxidation and total antioxidant status in upper gastrointestinal tract cancers

Gastroenterologia Polska

Volumn 14, Issue 6, 2007, Pages 405-408

  Diakowska, Dorota ^a   Grabowski, Krzysztof ^a   Nienartowicz, Mirosław ^a   Markocka Ma̧czka, Krystyna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Antioxidants; Gastrointestinal cancers; Oxidative stress

Indexed keywords

MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; LABORATORY TEST; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; SPECTROPHOTOMETRY; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CANCER; UPPER GASTROINTESTINAL TRACT;

EID: 38349052265     PISSN: 12329886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Messmann H.: Squamous cell cancer of the oesophagus. Pract. Res. Clin. Gastroenterol., 2001, 15, 249-265.
2. Tew W.S., Kelsen D., Ilson D.: Targeted therapies for esophageal cancer. Oncologist, 2005, 10, 590-601.
3. Bakan E., Taysi S., Polat M., Dalga S., Umudum Z., Bakan N., Gumus M.: Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn. J. Clin. Oncol., 2002, 32, 162-166.
4. El-Rifai W., Powell S.: Molecular biology of gastric cancer. Semin. Radiat. Oncol., 2002, 12, 128-140.
5. Wiseman H., Halliwell B.: Damage of DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J., 1996, 313, 17-29.
6. Marnett L.J.: Oxyradicals and DNA damage. Carcinogenesis, 2000, 21, 361-370.
7. Skrzydlewska E., Sulkowski S., Koda M., Zalewski B., Kanczuga-Koda L., Sułkowska M.: Lipid peroxidation and antioxidant status in colorectal cancer. World J. Gastroenterol., 2005, 11, 403-406.
8. Erata G., Kanbagli O., Durlanik O., Bulut T., Toker G., Uysal M.: Induced oxidative stress and decreased expression of inducible heat shock protein 70 (ihsp70) in patients with colorectal adenocarcinomas. Jpn. J. Clin. Oncol., 2005, 35, 74-78.
9. Farinati F., Cardin R., Degan P., Rugge M., Di Mario F., Bonvicini P., Naccarato R.: Oxidative DNA damage accumulation in gastric carcinogenesis. Gut, 1998, 42, 351-356.
10. Motta M., Pistone G., Franzone M., Romeo M.: Antibodies against ox-LDL serum levels in patients with hepatocellular carcinoma. Panminerva Med., 2003, 45, 69-73.
11. Suzuki K., Ito Y., Wakai K., Kawado M., Hashimoto S., Toyoshima H., Kojima M., Tokudome S., Hayakawa N., Watanabe Y., Tamakoshi K., Suzuki S., Ozasa K.: Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case-control study nested in the Japan collaborative cohort study. Cancer Epidemiol. Biomarkers Prev., 2004, 13, 1781-1787.
12. Skrzydlewska E., Kozuszko B., Sulkowska M., Zalewski B., Kozlowski M., Snarska J., Puchalski Z., Sulkowski S., Skrzydlewska Z.: Antioxidant potential in esophageal, stomach and colorectal cancers. Hepatogastroenterology, 2003, 50, 126-131.
13. Levy R.D., Oosthuizen M.M., Degiannis E., Lambrechts H.: Elevated reversible and irreversible lipid peroxidation in human oesophageal cancer. Anticancer Res., 1998, 18, 1325-1328.
14. Khanzode S., Khanzode S., Dakhale G.: Serum and plasma concentration of oxidants and antioxidants in patients of Helicobacter pylori gastritis and its correlation with gastric cancer. Cancer Lett., 2003, 195, 27-31.
15. Ray G., Batra S., Shukla N., Deo S., Raina V., Ashok S., Husain S.: Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res. Treat., 2000, 59, 163-170.
16. Khanzode S., Muddeshwar M., Khanzode S., Dakhale G.: Antioxidant enzymes and lipid peroxidation in different stages of breast cancer. Free Radic. Res., 2004, 38, 81-85.
17. Sobin L.H., Wittekind C.: TMN classification of malignant tumors. 6 ed., John Wiley and Sons, Hoeboken, New Jersey 2002.
18. Bartosz G.: Druga twarz tlenu. Wydawnictwo Naukowe PWN, Warszawa 2001.
19. Bonde P., Gao D., Chen L., Duncan M., Miyashita T., Montgomery E., Harmon J., Wei C.: Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus. J. Thorac. Cardiovasc. Surg., 2007, 133, 74-81.
20. Mantovani G., Maccio A., Madeddu C., Mura L., Massa E., Gramignano G., Lusso M., Murgia V., Camboni P., Ferreli L.: Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment. J. Cell. Mol. Med., 2002, 6, 570-582.
21. Manoharan S., Kolanjiappan K., Kayalvizhi M.: Enhanced lipid peroxidation and impaired enzymic antioxidant activities in the erythrocytes of patients with cervical carcinoma. Cell. Mol. Biol. Lett., 2004, 9, 699-707.
22. Mayo J.C., Tan D.X., Sainz R.M., Lopez-Burillo S., Reiter R.I.: Oxidative damage to catalase induced by peroxyl radicals: functional protection by melatonin and other antioxidants. Free Radic. Res., 2003, 37, 543-553.
23. Bartsch H., Nair J.: Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect. Prev., 2004, 28, 385-391.
24. Chen J.W., Chen Y.H., Lin S.J.: Long-term exposure to oxidized low-density lipoprotein enhances tumor necrosis factor-α-stimulated endothelial adhesiveness of monocytes by activating superoxide generation and redox-sensitive pathways. Free Radic. Biol. Med., 2006, 40, 817-826.
25. Zettler M., Prociuk M., Austria A., Massaeli H., Zhong G., Pierce G..: OxLDL stimulates cell proliferation through a general induction of cell cycle proteins. Am. J. Physiol. Heart Circ. Physiol., 2003, 284, H644-H653.
26. Fuhrman B., Wolfovitz E., Cogan U., Brook G.: Hypocholesterolemia and cancer: tumor cells induce enhanced LDL uptake by non-tumor cells and stimulate oxidative modification of LDL. Pathophysiology, 1999, 6, 205-210.
27. Furman B., Oiknine J., Keidar S., Ben-Yaish L., Kaplan M., Aviram M.: Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Free Radic. Biol. Med., 1997, 23, 34-46.
28. Hulten L., Ullstrom C., Krettek A., Reyk D., Marklund S., Dahlgren C., Wiklund O.: Human macrophages limit oxidation products in low density lipoprotein. Lipids Health Dis., 2005, 4, 1-11.
29. Chajes V., Mahon M., Kostner G.: Influence of LDL oxidation on the proliferation of human breast cancer cells. Free Radic. Biol. Med., 1996, 20, 113-120.
30. Witztum J.L., Steinberg D.: Role of oxidized low density lipoprotein in atherogenesis. J Clin. Invest., 1991, 88, 1785-1792.
31. Steinerova A., Racek J., Stozicky F., Zima T., Fialova L., Lapin A.: Antibodies against oxidized LDL - theory and clinical use. Physiol. Res., 2001, 50, 131-141.
32. Lee G., Chung H., Lee K., Ahn H.: Antioxidant vitamins and lipid peroxidation in patients with cervical intraepithelial neoplasia. J. Korean Med. Sci., 2005, 20, 267-272.
33. Manoharan S., Baskar A., Manivasagam T., Subramanian P.: Circadian rhythmicity of plasma lipid peroxidation and antioxidants in oral squamous cell carcinoma. Singapore Med. J., 2005, 46, 184-188.